Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study

被引:0
作者
Lei Li
XinXin Kou
XiaoJie Feng
MingChuan Zhang
HongTu Chao
LiYing Wang
机构
[1] The Affiliated Tumor Hospital of Zhengzhou University,Department of Gynecologic Oncology
来源
Radiation Oncology | / 10卷
关键词
Radical Hysterectomy; Cervical Cancer Patient; Paraaortic Lymph Node; Pelvic Recurrence; Vaginal Cuff;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 130 条
[1]  
Gray HJ(2008)Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy J Natl Com pr Canc Netw 6 47-52
[2]  
Landoni F(1997)Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer Lancet 350 535-540
[3]  
Maneo A(2002)Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy Acta Obstet Gynecol Scand 81 1144-1151
[4]  
Colombo A(2006)A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 169-176
[5]  
Placa F(2006)Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix Am J Obstet Gynecol 194 43-48
[6]  
Milani R(2000)Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 1606-1613
[7]  
Perego P(2005)Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma Gynecol Oncol 96 407-414
[8]  
Takeda N(1995)Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure Int J Radiat Oncol Biol Phys 31 31-36
[9]  
Sakuragi N(2012)20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy Gynecol Oncol 124 63-67
[10]  
Takeda M(2013)Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIBcervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience Int J Gynecol Cancer 23 567-575